Temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients (Approved in KR, US, EU, Canada)
Treatment of upper limb spasticity in adult patients (Approved in KR)
Temporary improvement in the appearance of moderate to severe lateral canthal lines associated with orbicularis oculi activity in adult patients (Approved in KR)
Treatment of blepharospasm associated with dystonia in adult patients (Approved in KR)
HI PureTM Technology (KR patent No.13-39349, US Patent No. 9,512,418)
Somatropin (human growth hormone)
Indication
Growth hormone replacement therapy in adults with growth hormone deficiency
rhEPO (recombinant human erythropoietin)
Indication
Growth hormone replacement therapy in adults with growth hormone deficiency
rhEPO (recombinant human erythropoietin)
Indication
Anemia in chronic renal failure
rhEGF (=recombinant human Epidermal Growth Factor)
